Stig Östlund

fredag, juli 08, 2016

Ticagrelor is an antiplatelet therapy that is an alternative to aspirin for preventing recurrent stroke. Does ticagrelor produce better outcomes than aspirin? New research findings are summarized in a short video:

--> The SOCRATES Trial — NEJM: Quick Take Video Summary from The New England Journal of Medicine



Bloggarkiv